Chondrogenic differentiation of human adipose-derived stem cells: A new path in articular cartilage defect management?

41Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

According to data published by the Centers for Disease Control and Prevention, over 6 million people undergo a variety of medical procedures for the repair of articular cartilage defects in the U.S. each year. Trauma, tumor, and age-related degeneration can cause major defects in articular cartilage, which has a poor intrinsic capacity for healing. Therefore, there is substantial interest in the development of novel cartilage tissue engineering strategies to restore articular cartilage defects to a normal or prediseased state. Special attention has been paid to the expansion of chondrocytes, which produce and maintain the cartilaginous matrix in healthy cartilage. This review summarizes the current efforts to generate chondrocytes from adipose-derived stem cells (ASCs) and provides an outlook on promising future strategies. © 2014 Jan-Philipp Stromps et al.

Cite

CITATION STYLE

APA

Stromps, J. P., Paul, N. E., Rath, B., Nourbakhsh, M., Bernhagen, J., & Pallua, N. (2014). Chondrogenic differentiation of human adipose-derived stem cells: A new path in articular cartilage defect management? BioMed Research International, 2014. https://doi.org/10.1155/2014/740926

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free